妊娠期疟疾间歇性预防治疗:双氢青蒿素-哌喹目标浓度的优化
在300名未感染HIV的孕妇中开展安慰剂对照试验,随机接受每8周磺胺多辛-乙胺嘧啶、每8周双氢青蒿素-哌喹(DHA-PQ)或每4周DHA-PQ。模型定义哌喹目标静脉血浆浓度13.9 ng/mL可提供99%保护;高于目标浓度时间每增加10天与胎盘寄生虫血症、早产和低出生体重的 odds 降低相关,但哌喹浓度升高与QT间期延长相关。模拟提示每日或每周低剂量给药可维持谷浓度高于目标并降低峰浓度。
要点
- 哌喹目标静脉血浆浓度13.9 ng/mL可提供99%保护。
- 高于目标浓度时间每增加10天,胎盘寄生虫血症、早产和低出生体重 odds 降低。
- 哌喹浓度升高与QT间期延长相关。
核心结论
- DHA-PQ间歇性预防治疗的保护效力与较高药物暴露强相关。
- 作者认为需开展替代DHA-PQ给药策略的疗效和安全性研究。
研究设计与样本
- 300名未感染HIV的孕妇在妊娠12-20周入组安慰剂对照试验,随机接受每8周磺胺多辛-乙胺嘧啶、每8周DHA-PQ或每4周DHA-PQ。
- 每4周进行哌喹药代动力学采样,并在30名孕妇妊娠28周时进行密集药代动力学亚研究。
- 评估哌喹暴露与妊娠期恶性疟原虫感染、分娩结局(胎盘疟疾、低出生体重、早产)及毒性风险的关系,并模拟新给药方案。
主要发现
- 模型定义的哌喹目标静脉血浆浓度13.9 ng/mL可提供99%保护,避免妊娠期恶性疟原虫感染。
- 高于目标哌喹浓度的时间每增加10天,与胎盘寄生虫血症、早产和低出生体重的 odds 降低相关。
- 哌喹浓度升高与QT间期延长相关。
- 模拟提示每日或每周给予较低剂量哌喹,相比标准给药,可维持哌喹谷浓度高于目标浓度并降低峰浓度,可能限制毒性。
关键数值与推荐
- 模型定义的哌喹目标静脉血浆浓度为13.9 ng/mL,提供99%保护。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需开展替代DHA-PQ间歇性预防治疗给药策略的疗效和安全性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dihydroartemisinin-piperaquine (DHA-PQ) is highly efficacious as intermittent preventive therapy for malaria during pregnancy (IPTp). Determining associations between piperaquine (PQ) exposure, malaria risk, and adverse birth outcomes informs optimal dosing strategies. METHODS: Human immunodeficiency virus-uninfected pregnant women (n = 300) were enrolled in a placebo-controlled trial of IPTp at 12-20 weeks' gestation and randomized to sulfadoxine-pyrimethamine every 8 weeks, DHA-PQ every 8 weeks, or DHA-PQ every 4 weeks during pregnancy. Pharmacokinetic sampling for PQ was performed every 4 weeks, and an intensive pharmacokinetic substudy was performed in 30 women at 28 weeks' gestation. Concentration-effect relationships were assessed between exposure to PQ; the prevalence of Plasmodium falciparum infection during pregnancy; outcomes at delivery including placental malaria, low birth weight, and preterm birth; and risks for toxicity. Simulations of new dosing scenarios were performed. RESULTS: Model-defined PQ target venous plasma concentrations of 13.9 ng/mL provided 99% protection from P. falciparum infection during pregnancy. Each 10-day increase in time above target PQ concentrations was associated with reduced odds of placental parasitemia, preterm birth, and low birth weight, though increases in PQ concentrations were associated with QT interval prolongation. Modeling suggests that daily or weekly administration of lower dosages of PQ, compared to standard dosing, will maintain PQ trough levels above target concentrations with reduced PQ peak levels, potentially limiting toxicity. CONCLUSIONS: The protective efficacy of IPTp with DHA-PQ was strongly associated with higher drug exposure. Studies of the efficacy and safety of alternative DHA-PQ IPTp dosing strategies are warranted. CLINICAL TRIALS REGISTRATION: NCT02163447.
引用
- Savic RM, Jagannathan P, Kajubi R, et al. Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine. Clin Infect Dis. 2018. PMID: 29547881. doi:10.1093/cid/ciy218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。